About ELGIA THERAPEUTICS, INC.
Elgia Therapeutics is a venture-backed biopharmaceutical company pioneering novel molecular approaches for the treatment of metabolic, inflammatory, and fibrotic diseases. The leadership team consists of world-renowned scientists with expertise in innate immunity, metabolic syndromes, inflammatory processes, and drug discovery.
Pioneering novel molecular approaches for the treatment of metabolic, inflammatory, and fibrotic diseasesDrug discovery and development of therapeuticsExpertise in innate immunity, inflammation, and wound healingResearch on key enzymes that control inflammation and cell demiseLeadership in disease pharmacology and signal transduction pathways
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to ELGIA THERAPEUTICS, INC. right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.